CSG’s Post-IPO Pain Deepens as First Earnings Report Looms

Czech defense giant CSG's shares have fallen 21% in April, trading at €18.70, far below the €24 IPO price. Despite a €15 billion backlog, market skepticism persists ahead of May 20 earnings.

The Czechoslovak Group’s stock debut was supposed to mark a new chapter for the Czech defense conglomerate. Instead, four months on, investors who bought in at the January 2026 IPO are nursing heavy losses.

Shares of CSG closed at €18.70 at the end of April, representing a monthly decline of roughly 21 percent. The stock listed on Euronext Amsterdam and the Prague Stock Exchange at the equivalent of just over €24, meaning early investors are sitting firmly in the red. After hitting a post-IPO high of €35.50, the shares suffered a brutal correction that took them to a 52-week low of €17.95. By Friday, the stock had settled at €18.42, down a marginal 0.16 percent on the day.

The relentless selling pressure has pushed the Relative Strength Index into oversold territory — a technical signal that often hints at a short-term bounce. But market watchers caution that such readings are no guarantee of a trend reversal.

A €15 Billion Backlog Meets Market Skepticism

The market’s cold shoulder stands in stark contrast to the company’s operational heft. CSG, controlled by billionaire Michal Strnad, entered 2026 with an order backlog of roughly €15 billion and a project pipeline worth €27 billion. The land systems and medium- and large-caliber ammunition divisions are driving growth, while the acquisition of The Kinetic Group at the end of 2024 made CSG the largest producer of small-caliber ammunition in the Western world, securing steady revenue streams from both civilian and military markets in the US and Europe.

For the full year, management is targeting revenue between €7.4 billion and €7.6 billion, with an adjusted EBIT margin of 24 to 25 percent.

All Eyes on May 20

The next major test comes on May 20, 2026, when CSG publishes its first complete quarterly results as a publicly traded company. Analysts will be looking for confirmation that the company is on track to hit its annual targets, and they will also scrutinize the integration of recent international acquisitions.

Despite the stock’s dismal performance, the analyst community remains broadly bullish. The average price target stands at €35.58 — implying a near-doubling from current levels. For now, however, the market is focused on finding a technical floor. If support at €17.95 holds until the May 20 earnings release, the first quarterly report could finally draw a line under the post-IPO correction.